Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes
Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type 1 Diabetes, marking the successful enrollment of 100 patients without any serious adverse events or discontinuations reported. This trial, the first-ever precision medicine Phase 3 study in Type 1 Diabetes, is currently underway in the United States […]